CD58 and myeloid sarcoma: We conducted a Mendelian randomization analysis leveraging the cis-instrumental variable for CD58 in the International Multiple Sclerosis Genetics Consortium (23) and found additional evidence for a potential causal role of circulating CD58 in MS development (Table 3).